Alerus Financial Corporation reports Q1 2026 results on April 30 with an unusually sharp divergence between cautious analyst consensus and suddenly bullish options positioning.
The most striking signal heading into the print is the options market. Put/call ratio has collapsed to 0.03 — the lowest reading of the past 52 weeks, well below its 20-day average of 0.89. That is a dramatic rotation away from downside protection: for weeks the PCR ran above 1.4, suggesting persistent hedging demand, but that overhang has cleared entirely in the past two weeks. The stock has recovered alongside that shift, gaining 9% over the past month to close at $25.75, with a modest 1% pullback on Tuesday.
Short interest is not a meaningful story here. At 2.9% of free float, it has actually fallen 10% over the past week even as it ticked up 11% over the month. Availability is wide open — borrow demand is low and there is no squeeze pressure in the lending market. Cost to borrow has roughly doubled over the past month to just under 1%, but at that absolute level it remains firmly in the inconsequential range. The ORTEX short score of 41.5 sits comfortably in the mid-range and has drifted lower this week. Overall, the lending market signals a relaxed short side rather than any building conviction against the stock.
The analyst debate is notably subdued. The most recent changes — from January 2026 — show DA Davidson and Keefe, Bruyette & Woods both nudging targets higher while keeping neutral ratings, while Hovde Group downgraded to Market Perform in early January. Raymond James remains the outlier with a Strong Buy and a $27 target. The mean consensus target sits at $26.60 against a current price of $25.75, implying modest upside that is consistent with a story the Street broadly views as fairly valued. The bull case rests on net interest income growth (NII up 4.7% last quarter) and strengthening capital ratios (CET1 at 10.8%). Bears point to loan book contraction — commercial real estate construction runoff drove a 5.3% sequential decline — and a fee income line that has been running below expectations. The stock's forward earnings yield ranks in only the 4th percentile on EPS surprise, which is a note of caution on estimate reliability, though its 12-month forward EPS growth ranks in the 90th percentile.
Institutional flows offer one quiet supporting data point. Dimensional, Vanguard, and Geode all added shares in Q1 2026, with Dimensional adding 33,000 shares — modest but directionally consistent with the options market's recent tilt toward the upside. Insider activity from late February was routine: the CEO and COO sold small tranches from fresh awards, the kind of tax-driven activity that carries little signal.
The print will test whether the fee income and loan growth trajectory has stabilised enough to justify the multiple re-rating — P/E has expanded by nearly one full turn over the past month to 9.8x — or whether the bear case on credit quality and deposit runoff reasserts itself.
See the live data behind this article on ORTEX.
Open ALRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
